Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven R Brenner

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Age and Ageing|January 29, 2010
Hypothesis: intestinal barrier permeability may contribute to cognitive dysfunction and dementiaSteven R Brenner
Neurology|February 19, 2014
Mitochondrial encephalomyopathies--fifty years on: the Robert Wartenberg LectureSteven R Brenner
Medical Hypotheses|April 28, 2020
Covid-19, TMPRSS2, and whether android regulation affects pandemic virus gender incidence and age distribution of diseaseSteven R Brenner
Archives of Neurology|February 13, 2003
Vitamin E treatment affects the progression of mild cognitive impairment to dementiaSteven R Brenner
Neurology|May 10, 2006
An open study of botulinum-A toxin treatment of trigeminal neuralgiaSteven R Brenner
Neurology|November 21, 2007
Re: Altered arterial function in migraine of recent onsetSteven R Brenner
Neurology|August 5, 2011
Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiencySteven R Brenner
Medical Hypotheses|November 14, 2012
Blue-green algae or cyanobacteria in the intestinal micro-flora may produce neurotoxins such as Beta-N-Methylamino-L-Alanine (BMAA) which may be related to development of amyotrophic lateral sclerosis, Alzheimer's disease and Parkinson-Dementia-Complex in humans and Equine Motor Neuron Disease in horsesSteven R Brenner
Neurology|January 21, 2009
Transmissible spongiform encephalopathy in the 21st Century: neuroscience for the clinical neurologistSteven R Brenner, Paul W Brown
Neurology|May 1, 2013
Mouse brain kaleidoscopeSteven R Brenner, Fernando Calamante, Robert A Gross
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Age and Ageing|January 29, 2010
Hypothesis: intestinal barrier permeability may contribute to cognitive dysfunction and dementiaSteven R Brenner
Neurology|February 19, 2014
Mitochondrial encephalomyopathies--fifty years on: the Robert Wartenberg LectureSteven R Brenner
Medical Hypotheses|April 28, 2020
Covid-19, TMPRSS2, and whether android regulation affects pandemic virus gender incidence and age distribution of diseaseSteven R Brenner
Archives of Neurology|February 13, 2003
Vitamin E treatment affects the progression of mild cognitive impairment to dementiaSteven R Brenner
Neurology|May 10, 2006
An open study of botulinum-A toxin treatment of trigeminal neuralgiaSteven R Brenner
Neurology|November 21, 2007
Re: Altered arterial function in migraine of recent onsetSteven R Brenner
Neurology|August 5, 2011
Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiencySteven R Brenner
Medical Hypotheses|November 14, 2012
Blue-green algae or cyanobacteria in the intestinal micro-flora may produce neurotoxins such as Beta-N-Methylamino-L-Alanine (BMAA) which may be related to development of amyotrophic lateral sclerosis, Alzheimer's disease and Parkinson-Dementia-Complex in humans and Equine Motor Neuron Disease in horsesSteven R Brenner
Neurology|January 21, 2009
Transmissible spongiform encephalopathy in the 21st Century: neuroscience for the clinical neurologistSteven R Brenner, Paul W Brown
Neurology|May 1, 2013
Mouse brain kaleidoscopeSteven R Brenner, Fernando Calamante, Robert A Gross
Pageof 4